Table of Contents
Volume 7 | Issue 11
Publication Date: December 2007- Abstract
- No Access
- Pay-Per View
- Full Text
- Add to Cart
Editorial | ||
821 |
The Measure of Our Success George W. Sledge, Jr |
|
Comprehensive Reviews | ||
833-840 |
Breast Cancer Risk Management Jennifer G. Reeder, Victor G. Vogel |
|
841-849 |
Evolving Nonendocrine Therapeutic Options for Metastatic Breast Cancer: How Adjuvant Chemotherapy Influences Treatment PierFranco Conte, Valentina Guarneri, Carmelo Bengala |
|
Original Contributions | ||
850-856 |
Phase II Study of Weekly Albumin-Bound Paclitaxel for Patients with Metastatic Breast Cancer Heavily Pretreated with Taxanes Joanne L. Blum, Michael A. Savin, Gerald Edelman, John E. Pippen, Nicholas J. Robert, Brian V. Geister, Robert L. Kirby, Alicia Clawson, Joyce A. O'Shaughnessy |
|
857-860 |
Safety Profile and Activity of Lower Capecitabine Dose in Patients with Metastatic Breast Cancer David Rossi, Paolo Alessandroni, Vincenzo Catalano, Paolo Giordani, Stephano Luzi Fedeli, Anna Fedeli, Anna Maria Baldelli, Virginia Casadei, Monica Ceccolini, Giuseppina Catalano |
|
861-866 |
Phase I/II Pharmacokinetic Study of Pemetrexed and Epirubicin in Patients with Locally Advanced or Metastatic Breast Cancer Robert Paridaens, Luc Dirix, Herlinde Dumez, Annemie Prové, Hans Wildiers, Ana Alvarez, Celia Tosello Oliveira, Jane Latz, Lorinda Simms, Allen Melemed |
|
867-874 |
Clinical Course of 771 Patients with Bilateral Breast Cancer: Characteristics Associated with Overall and Recurrence-Free Survival Garth Beinart, Ana M. Gonzalez-Angulo, Kristine Broglio, Jaime Mejia, Anthony Ruggeri, Eric Mininberg, Gabriel N. Hortobagyi, Vicente Valero |
|
875-882 |
Bilateral Prophylactic Oophorectomy and Bilateral Prophylactic Mastectomy in a Prospective Cohort of Unaffected BRCA1 and BRCA2 Mutation Carriers Tara M. Friebel, Susan M. Domchek, Susan L. Neuhausen, Theresa Wagner, D. Gareth Evans, Claudine Isaacs, Judy E. Garber, Mary B. Daly, Rosalind Eeles, Ellen Matloff, Gail Tomlinson, Henry T. Lynch, Nadine Tung, Joanne L. Blum, Jeffrey Weitzel, Wendy S. Rubinstein, Patricia A. Ganz, Fergus Couch, Timothy R. Rebbeck |
|
883-889 |
Molecular Detection and Prognostic Value of Circulating Cytokeratin-19 Messenger RNA–Positive and HER2 Messenger RNA–Positive Cells in the Peripheral Blood of Women with Early-Stage Breast Cancer Michail Ignatiadis, Maria Perraki, Stella Apostolaki, Eleni Politaki, Nikos Xenidis, Maria Kafousi, Efstathios Stathopoulos, Evi Lianidou, Christos Sotiriou, Vassilis Georgoulias, Dimitris Mavroudis |
|
Case Reports | ||
890-891 |
Delayed Resolution of Jaundice in the Arm of a Patient with Impaired Lymphatic Drainage: A Case Report Roger Y. Tsang, John R. Mackey |
|
892-894 |
Breast Carcinoma with Neuroendocrine Differentiation and Myocardial Metastases Bryan T. Hennessy, Michael Z. Gilcrease, Edward Kim, Ana M. Gonzalez-Angulo |
|
Current Trial | ||
895-900 |
National Cancer Institute of Canada Clinical Trials Group MAP.3 Trial: Evaluation of Exemestane to Prevent Breast Cancer in Postmenopausal Women Paul E. Goss, Harriet Richardson, Rowan Chlebowski, Dianne Johnston, Gloria E. Sarto, Elizabeth Maunsell, James N. Ingle, José E. Alés-Martinez |
|
Clinical Trials | ||
901 |
Selected Clinical Trials in Breast Cancer CIG Media Group |
|